14.03.2018 • News

BP Licenses PTA Technology to Socar Turkey

BP Licenses PTA Technology to Socar Turkey (c) BP
BP Licenses PTA Technology to Socar Turkey (c) BP

BP is licensing its latest generation purified terephthalic acid (PTA) technology to SOCAR Turkey Enerji. The Turkish company will use the technology for a new 900,000 t/y plant in Aliaga, which is expected to go on stream by 2023, pending a final investment decision.

“This investment is highly strategic for us, fulfilling our intent to create a value chain by integrating our newly-announced aromatics complex adjacent to the Star refinery and Petkim plant in Aliaga with the most competitive PTA technology,” said Emil Eminov, chief operating officer of SOCAR Turkey. “This will create the most competitive asset in Turkey and the Middle East and will serve the high demand for PTA in Turkey and surrounding regions.”

The Star refinery, which is due to be commissioned in September of this year, is reported to include production of 1 million t/y of reformate and mixed xylenes, along with naphtha feedstock for Petkim. SOCAR Turkey, part of Azerbaijan’s energy group SOCAR, acquired Petkim in 2008.

BP said its PTA technology has significantly lower capital and operating costs compared to rival processes. The UK-based group has an alliance with French engineering and construction group Technip for PTA projects, which was extended in December 2016 to include acetic acid.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.